Overview

A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy

Status:
Terminated
Trial end date:
2019-07-12
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and adverse effects of mifepristone tablets in widely used conditions, to evaluate the relationship between interests and risks used in general or special populations, to further observe the safety and efficacy of drugs.
Phase:
Phase 4
Details
Lead Sponsor:
China Resources Zizhu Pharmaceutical Co., Ltd.
Treatments:
Mifepristone